These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15488139)

  • 21. Efficacy of protected renal artery primary stenting in the solitary functioning kidney.
    Klonaris C; Katsargyris A; Alexandrou A; Tsigris C; Giannopoulos A; Bastounis E
    J Vasc Surg; 2008 Dec; 48(6):1414-22. PubMed ID: 18829238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal function and outcome of PTRA and stenting for atherosclerotic renal artery stenosis.
    Ramos F; Kotliar C; Alvarez D; Baglivo H; Rafaelle P; Londero H; Sánchez R; Wilcox CS
    Kidney Int; 2003 Jan; 63(1):276-82. PubMed ID: 12472793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective randomized trial of operative vs interventional treatment for renal artery ostial occlusive disease (RAOOD).
    Balzer KM; Pfeiffer T; Rossbach S; Voiculescu A; Mödder U; Godehardt E; Sandmann W
    J Vasc Surg; 2009 Mar; 49(3):667-74; discussion 674-5. PubMed ID: 19135837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trial.
    Jaff MR; Bates M; Sullivan T; Popma J; Gao X; Zaugg M; Verta P;
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):343-50. PubMed ID: 22511402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal angioplasty and stenting under protection: the way for the future?
    Henry M; Henry I; Klonaris C; Polydorou A; Rath P; Lakshmi G; Rajacopal S; Hugel M
    Catheter Cardiovasc Interv; 2003 Nov; 60(3):299-312. PubMed ID: 14571477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Two cases of atherosclerotic renal artery stenosis treated by percutaneous transluminal renal angioplasty and intravascular stent placement, leading to improvement of hypertension and renal function].
    Saigusa T; Tajima O; Nishiyama J; Nakabayashi I; Miura S; Kobayashi S
    Nihon Jinzo Gakkai Shi; 2002 Mar; 44(2):102-8. PubMed ID: 11974949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The benefit of STent placement and blood pressure and lipid-lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR-study: rationale and study design.
    Bax L; Mali WP; Buskens E; Koomans HA; Beutler JJ; Braam B; Beek FJ; Rabelink TJ; Postma CT; Huysmans FT; Deinum J; Thien T; Schultze Kool LJ; Woittiez AJ; Kouwenberg JJ; van den Meiracker AH; Pattynama PM; van de Ven PJ; Vroegindeweij D; Doorenbos CJ; Aarts JC; Kroon AA; de Leeuw PW; de Haan MW; van Engelshoven JM; Rutten MJ; van Montfrans GA; Reekers JA; Plouin PF; La Batide Alanore A; Azizi M; Raynaud A; Harden PN; Cowling M;
    J Nephrol; 2003; 16(6):807-12. PubMed ID: 14736007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time course of inflammatory response after renal artery stenting in patients with atherosclerotic renal stenosis.
    Li JJ; Fang CH; Jiang H; Huang CX; Hui RT; Chen MZ
    Clin Chim Acta; 2004 Dec; 350(1-2):115-21. PubMed ID: 15530467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of renal angioplasty failure by percutaneous renal artery stenting with Palmaz stents: midterm technical and clinical results.
    Boisclair C; Therasse E; Oliva VL; Soulez G; Bui BT; Quérin S; Robillard P
    AJR Am J Roentgenol; 1997 Jan; 168(1):245-51. PubMed ID: 8976953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renovascular hypertension: diagnostic and therapeutic challenges.
    Bosmans JL; De Broe ME
    JBR-BTR; 2004; 87(1):32-5. PubMed ID: 15055332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does percutaneous transluminal renal artery angioplasty improve blood pressure control and renal function in patients with atherosclerotic renal artery stenosis?
    Wolak T; Belkin A; Ginsburg V; Greenberg G; Mayzler O; Bolotin A; Paran E; Szendro G
    Isr Med Assoc J; 2011 Oct; 13(10):619-24. PubMed ID: 22097232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal function and survival after renal artery stent revascularization may be influenced by embolic debris.
    Dorros G; Jaff M; Mathiak L; He T; Minor R; Harner R; McCurdy S; Krause P
    J Invasive Cardiol; 2004 Apr; 16(4):189-95. PubMed ID: 15152144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive value of renal resistive index in percutaneous renal interventions for atherosclerotic renal artery stenosis.
    Yuksel UC; Anabtawi AG; Cam A; Poddar K; Agarwal S; Goel S; Kim E; Bajzer C; Gornik HL; Shishehbor MH; Tuzcu EM; Kapadia SR
    J Invasive Cardiol; 2012 Oct; 24(10):504-9. PubMed ID: 23043033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA; Onuigbo NT
    QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous transluminal revascularization for renal artery stenosis: Veterans Affairs Puget Sound Health Care System experience.
    Yutan E; Glickerman DJ; Caps MT; Hatsukami T; Harley JD; Kohler TR; Davies MG
    J Vasc Surg; 2001 Oct; 34(4):685-93. PubMed ID: 11668325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effectiveness of percutaneous transluminal renal artery stenting in treating atherosclerotic renal artery stenosis].
    Guo L; Gu Y; Zhang J; Li J; Yu H; Wang Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2010 Sep; 24(9):1037-40. PubMed ID: 20939468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective stenting and the course of atherosclerotic renovascular nephropathy.
    Campo A; Boero R; Stratta P; Quarello F
    J Nephrol; 2002; 15(5):525-9. PubMed ID: 12455719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ischemic renal disease: revascularization or conservative treatment?].
    Rodríguez Jornet A; Ibeas J; Ribera L; Real J; Perendreu J; Falcó J; Vallespín J; Allegué N; Giménez Gaibar A; García García M
    Nefrologia; 2005; 25(3):258-68. PubMed ID: 16053007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal artery stenting: one year outcome on BP control and antihypertensive medication.
    Sathyamurthy I; Sudhakar K; Jayanthi K; Subramanyan K; Ramachandran P; Mao R; Samuel KM
    J Assoc Physicians India; 2014 Mar; 62(3):228-31. PubMed ID: 25327064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetes mellitus does not preclude stabilization or improvement of renal function after stent revascularization in patients with kidney insufficiency and renal artery stenosis.
    Silva JA; Potluri S; White CJ; Collins TJ; Jenkins JS; Subramanian R; Ramee SR
    Catheter Cardiovasc Interv; 2007 May; 69(6):902-7. PubMed ID: 17192944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.